PVI
OMIC

Pura Vida Investments’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Pura Vida Investments’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,018
Closed -$1.05M – 292
2021
Q4 		$1.05M Buy
+3,018
New +$1.17M 0.04% 177
2021
Q3 		– Sell
-5,202
Closed -$4.29M – 339
2021
Q2 		$4.29M Buy
+5,202
New +$4.03M 0.13% 130

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pura Vida Investments's OMIC Position: Q1 2022 in Review

Pura Vida Investments sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2022, closing a stake of 3,018 shares — an estimated $1.05M sold.

Pura Vida Investments first reported a position in OMIC in Q2 2021 and held it in 2 quarters. The position peaked at $4.29M in Q2 2021. 69 funds tracked by Wall St. Rank hold OMIC as of Q1 2022.

  • Pura Vida Investments reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Pura Vida Investments sold 3,018 Singular Genomics Systems, Inc. Common Stock shares in Q1 2022, an estimated $1.05M.
  • Pura Vida Investments first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Pura Vida Investments's Singular Genomics Systems, Inc. Common Stock position peaked at $4.29M in Q2 2021.
  • 69 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.